Novartis gains after raising core profit outlook
27/10/2026 08:23
BUZZ-Novartis gains after raising core profit outlook ** Swiss drugmaker Novartis NOVN.S is up around 2% to the top of Switzerland's blue-chip SMI index .SSMI after raising its 2026 core operating income guidance
** Vontobel says Q3 profitability "clearly" beat consensus despite weaker contributions from genericized products including Entresto, Promacta and Tasigna
** Shares up about 16% YTD as of previous close
($1 = 0.8273 Swiss francs)
(Reporting by Kira Britten)
Recent news on Novartis AG
See all newsEurope Research Roundup: Ambu, Intesa Sanpaolo, Solvay
Swiss pharma industry behind in technology and clinical trials, index shows
European shares rise as Democrats take US Congress, Novo Nordisk surges
European shares rise as Democratic sweep lifts clean energy, bank stocks
Europe set to open lower as Democratic sweep fuels AI regulation fears